|
Name |
6,9,12-Octadecatrienoic acid, methyl ester
|
Molecular Formula | C19H32O2 | |
IUPAC Name* |
methyl (6E,9E,12E)-octadeca-6,9,12-trienoate
|
|
SMILES |
CCCCC/C=C/C/C=C/C/C=C/CCCCC(=O)OC
|
|
InChI |
InChI=1S/C19H32O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19(20)21-2/h7-8,10-11,13-14H,3-6,9,12,15-18H2,1-2H3/b8-7+,11-10+,14-13+
|
|
InChIKey |
JFRWATCOFCPIBM-SPOHZTNBSA-N
|
|
Synonyms |
6,9,12-Octadecatrienoic acid, methyl ester; LN4NQN66K8; methyl 6,9,12-octadecatrienoate; Methyl-6,9,12-octadecatrienoate; Methyl (6E,9E,12E)-octatrienoate; Methyl-(6E,9E,12E)-octadeca-6,9,12-trienoate; 6,9,12-Octadecatrienoic acid, methyl ester, (6E,9E,12E)-; 132029-21-1; Methyl -linolenate; 2676-41-7; 6,9,12-Octadecatrienoic acid methyl ester; UNII-LN4NQN66K8; SCHEMBL23143236; SCHEMBL23143237; GAMMA-LINOLENICACIDMETHYLESTER; AKOS015902233; Methyl (6E,9E,12E)-6,9,12-octadecatrienoate; J-010026; Methyl (6E,9E,12E)-6,9,12-octadecatrienoate #
|
|
CAS | 132029-21-1 | |
PubChem CID | 5362805 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 292.5 | ALogp: | 6.2 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 21 | QED Weighted: | 0.241 |
Caco-2 Permeability: | -4.84 | MDCK Permeability: | 0.00004560 |
Pgp-inhibitor: | 0.018 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.095 | 20% Bioavailability (F20%): | 0.948 |
30% Bioavailability (F30%): | 0.939 |
Blood-Brain-Barrier Penetration (BBB): | 0.017 | Plasma Protein Binding (PPB): | 99.91% |
Volume Distribution (VD): | 1.599 | Fu: | 1.08% |
CYP1A2-inhibitor: | 0.912 | CYP1A2-substrate: | 0.269 |
CYP2C19-inhibitor: | 0.682 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.703 | CYP2C9-substrate: | 0.979 |
CYP2D6-inhibitor: | 0.683 | CYP2D6-substrate: | 0.76 |
CYP3A4-inhibitor: | 0.856 | CYP3A4-substrate: | 0.086 |
Clearance (CL): | 3.125 | Half-life (T1/2): | 0.876 |
hERG Blockers: | 0.119 | Human Hepatotoxicity (H-HT): | 0.846 |
Drug-inuced Liver Injury (DILI): | 0.015 | AMES Toxicity: | 0.002 |
Rat Oral Acute Toxicity: | 0.003 | Maximum Recommended Daily Dose: | 0.951 |
Skin Sensitization: | 0.97 | Carcinogencity: | 0.071 |
Eye Corrosion: | 0.912 | Eye Irritation: | 0.933 |
Respiratory Toxicity: | 0.425 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001605 | 0.765 | D0UE9X | 0.800 | ||||
ENC001660 | 0.765 | D0O1TC | 0.732 | ||||
ENC001714 | 0.703 | D0G2MW | 0.500 | ||||
ENC001711 | 0.703 | D0OR6A | 0.469 | ||||
ENC001094 | 0.662 | D0O1PH | 0.400 | ||||
ENC001645 | 0.657 | D0Q5XX | 0.387 | ||||
ENC001583 | 0.640 | D09ANG | 0.340 | ||||
ENC001435 | 0.629 | D0H2YX | 0.324 | ||||
ENC001549 | 0.625 | D09SRR | 0.298 | ||||
ENC001535 | 0.603 | D0PS6X | 0.291 |